Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Rangering i aksjer #38625
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Aksjekurs
$1.52
Markedsverdi
$907.46K
Endring (1 dag)
0.66%
Endring (1 år)
-88.59%
Land
US
Handel Enveric Biosciences, Inc. (ENVB)

Kategori

Pris ENVB pris med markedsverdi på B
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
ENVB
$1.52
Markedsverdi av Enveric Biosciences, Inc.(ENVB)
Markedsverdi: $907.46K
Per August 2026 har Enveric Biosciences, Inc. en markedsverdi på $907.46K. Dette gjør Enveric Biosciences, Inc. til det 38625th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Enveric Biosciences, Inc. fra 2005 til 2026
ENVB sammenlignet med topp 5 mest populære stocks
Pris på ENVB Eiendel B Markedsverdi for B Resultater
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$9,134,273 $907.46K
$5.453T +600,938,892.00%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$7,514,179 $907.46K
$4.486T +494,353,753.84%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$6,966,733 $907.46K
$4.159T +458,337,625.28%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$6,182,869 $907.46K
$3.691T +406,767,608.44%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$4,762,066 $907.46K
$2.843T +313,293,716.57%